Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2017
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, E Campo, O Hermine, et al.
Lancet (London, England)
|
September 9, 1995
The need for liver transplantation: a nationwide estimate based on consensus review
B Modan, O Shpilberg, Y Baruch, et al.
Bone Marrow Transplantation
|
March 30, 2001
Engraftment-associated hypophosphatemia--the role of cytokine release and steep leukocyte rise post stem cell transplantation
P Raanani, I Levi, F Holzman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2014
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, C Geisler, O Hermine, et al.
Leukemia
|
November 1, 1995
Transformation of chronic lymphocytic leukemia to multiple myeloma: clonal evolution of second malignancy?
O Shpilberg, Z Mark, M Biniaminov, et al.
Leukemia Research
|
December 1, 1995
Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemia
O Shpilberg, N Haddad, O Sofer, et al.
Transplantation
|
April 15, 1996
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients
R Or, A Nagler, O Shpilberg, et al.
Acta Haematologica
|
January 1, 1989
Aplastic crisis due to human B19 parvovirus infection in red cell pyrimidine-5'-nucleotidase deficiency
G Rechavi, A Vonsover, Y Manor, et al.
Leukemia Research
|
August 24, 1999
Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine
P Raanani, O Shpilberg, S Gillis, et al.
Blood
|
November 5, 1997
The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin
H Peretz, A Mulai, S Usher, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2017
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, E Campo, O Hermine, et al.
Lancet (London, England)
|
September 9, 1995
The need for liver transplantation: a nationwide estimate based on consensus review
B Modan, O Shpilberg, Y Baruch, et al.
Bone Marrow Transplantation
|
March 30, 2001
Engraftment-associated hypophosphatemia--the role of cytokine release and steep leukocyte rise post stem cell transplantation
P Raanani, I Levi, F Holzman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2014
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, C Geisler, O Hermine, et al.
Leukemia
|
November 1, 1995
Transformation of chronic lymphocytic leukemia to multiple myeloma: clonal evolution of second malignancy?
O Shpilberg, Z Mark, M Biniaminov, et al.
Leukemia Research
|
December 1, 1995
Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemia
O Shpilberg, N Haddad, O Sofer, et al.
Transplantation
|
April 15, 1996
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients
R Or, A Nagler, O Shpilberg, et al.
Acta Haematologica
|
January 1, 1989
Aplastic crisis due to human B19 parvovirus infection in red cell pyrimidine-5'-nucleotidase deficiency
G Rechavi, A Vonsover, Y Manor, et al.
Leukemia Research
|
August 24, 1999
Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine
P Raanani, O Shpilberg, S Gillis, et al.
Blood
|
November 5, 1997
The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin
H Peretz, A Mulai, S Usher, et al.
Page
of 10